<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="141214">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01884883</url>
  </required_header>
  <id_info>
    <org_study_id>MAILLEFERT 2010</org_study_id>
    <nct_id>NCT01884883</nct_id>
  </id_info>
  <brief_title>Evaluation of a Distraction-rotation Knee Unloader Brace in Patients With Medial Knee Osteoarthritis.</brief_title>
  <acronym>ORFEVRE</acronym>
  <official_title>Evaluation of a Distraction-rotation Knee Unloader Brace in Patients With Medial Knee Osteoarthritis.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Dijon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Dijon</source>
  <oversight_info>
    <authority>France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to confirm the biomechanical effects and evaluate functional
      benefits of a new knee brace combining valgus inducing effect on medial compartment and leg
      external rotation during the stance phase in patients with symptomatic medial knee
      osteoarthritis.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2010</start_date>
  <primary_completion_date type="Actual">December 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Pain score on visual analogic scale</measure>
    <time_frame>Baseline</time_frame>
    <safety_issue>No</safety_issue>
    <description>Pain was self-evaluated by patient on visual analogic scale (VAS: 0-100, 0 = no pain at all; 100 = worst pain appendix 1). Such pain is widely used and validated in the literature for the evaluation of knee osteoarthritis treatment outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain score on visual analogic scale</measure>
    <time_frame>Baseline + 5 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Pain was self-evaluated by patient on visual analogic scale (VAS: 0-100, 0 = no pain at all; 100 = worst pain appendix 1). Such pain is widely used and validated in the literature for the evaluation of knee osteoarthritis treatment outcome.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluation of the functional capacities: KOOS questionnaire.</measure>
    <time_frame>baseline</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of the functional capacities: KOOS questionnaire.</measure>
    <time_frame>baseline + 5 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">21</enrollment>
  <condition>Knee Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>Internal unicompartmental knee brace</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PROTEOR Internal unicompartmental knee brace</intervention_name>
    <arm_group_label>Internal unicompartmental knee brace</arm_group_label>
    <other_name>trademark : &quot; PROTEOR &quot; : code name 2H-200</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient understanding simple order and able to give written consent.

          -  Man or woman with age between 40 et 75 years

          -  Unilateral medial symptomatic knee osteoarthritis, defined using the American College
             of Rheumatology classification

          -  Radiologic grade II, III ou IV (Kellgren et Lawrence (KL) classification)

          -  Medial knee compartment (Medial K&amp;L g rade higher than lateral K&amp;L grade

          -  Knee pain  &gt; 40/100 on visual analog scale and &lt;30/100 for the other

          -  No change in medical treatment for at least 3 months.

          -  Latest radiographic image &lt; 12 months before inclusion

        Exclusion Criteria:

          -  Patient without healthcare insurance.

          -  Inflammatory knee arthritis,

          -  Indication of knee surgery

          -  Pregnancy, breastfeeding

          -  Associate neurologic or orthopaedic affection that interferes  with gait analysis

          -  Rapidly destructive arthritis.

          -  Alzheimer's disease, Parkinson's disease, motor neuronal disorders

          -  Patient under guardianship or tutelage
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Francis Maillefert</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Dijon - Department of Rheumatology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU de Dijon</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2013</verification_date>
  <lastchanged_date>June 21, 2013</lastchanged_date>
  <firstreceived_date>June 18, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
